🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether the addition of budesonid...
Status
Completed
Location
Children's Hospital of Philadelphia Emergency Department
Start Date
2006-12
Trial ID
NCT00393367
The primary objective of the study is to evaluate the efficacy of eslicarba...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-07
Trial ID
NCT00957047
Treatments Being Tested
This study is a Phase 2 multinational, double-blind, placebo-controlled, ra...
Status
Terminated
Location
Consultants in Epilepsy and Neurology, PLLC
Start Date
2022-12-27
Trial ID
NCT05473442
Treatments Being Tested
Methylphenidate (MPH) is a stimulant, FDA-approved for the treatment of att...
Status
Recruiting
Location
Miami VA Healthcare System, Miami, FL
Start Date
2023-08-14
Trial ID
NCT04419272
Treatments Being Tested
To evaluate the efficacy of the prophylaxis with phenytoin in the preventio...
Status
Terminated
Location
Hospital Universitari de Bellvitge
Start Date
2011-11
Trial ID
NCT01478035
This research study will look at the safety (e.g., the occurrence of side e...
Status
Completed
Location
Jefferson Headache Center
Start Date
2003-06
Trial ID
NCT00203229
Treatments Being Tested
The notion of genuine placebo effects on epileptic seizure events (i.e., ef...
Status
Recruiting
Location
Department of Epileptology, University Hospital Bonn
Start Date
2024-05-13
Trial ID
NCT06383689
Treatments Being Tested
Evaluating efficacy \& safety of lacosamide versus Placebo in a blinded fas...
Status
Completed
Location
Sp0982 028
Start Date
2015-04
Trial ID
NCT02408523
Treatments Being Tested
Epilepsy is one of the most common chronic neurological diseases, affecting...
Status
Unknown
Location
Toronto Western Hospital
Start Date
2010-06
Trial ID
NCT01126307
The purpose of this study is to determine whether Eslicarbazepine acetate (...
Status
Completed
Location
University of South Alabama Department of Neurology
Start Date
2008-12-02
Trial ID
NCT00988429
Treatments Being Tested